Skip Navigation


Bioinformatics Advance Access originally published online on February 5, 2004
This Article
Right arrow FREE Full Text (Print PDF) Freely available
Right arrow FREE Full Text (Screen PDF)
Right arrow All Versions of this Article:
20/7/1170    most recent
bth059v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Leung, F. C.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Leung, F. C.C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Bioinformatics 20(7) © Oxford University Press 2004; all rights reserved.

An evaluation of new criteria for CpG islands in the human genome as gene markers

Yong Wang and Frederick C.C. Leung *

Department of Zoology, University of Hong Kong, Pokfulam, Hong Kong, HKSAR, China

Received on April 3, 2003; revised on November 4, 2003; accepted on November 7, 2003
Advance Access Publication February 5, 2004

Motivation: Recently, more stringent criteria for CpG islands have been introduced to exclude Alu repeats, thereby enabling a higher proportion of CpG islands associating with genes to be identified. Using these new criteria, several types of associations between CpG islands and genes were investigated to further establish the importance of CpG islands as gene markers.

Results: The CpG islands were searched by CpGIE, a java software program developed for CpG island identification. CpGIE was advanced in identification accuracy compared with other tools. According to our results, about 70% of the identified CpG islands were associating with the human genes and over half of them are in the promoters. Furthermore, the investigation of genes in the confirmed gene model showed that 56% of them had a CpG island overlapping the transcription start sites. In comparison, the new criteria were found capable of filtering a large fraction of Alu repeats that was identified as CpG islands by the generally accepted criteria within the genes, but very few CpG islands associating with the promoters were affected. The genes in the predicted gene model were not obviously associated with CpG islands, suggesting that CpG islands can be used to evaluate the accuracy of gene annotation.

Availability: http://bioinfo.hku.hk/cpgieintro

Contact: fcleung{at}hkucc.hku.hk

* To whom correspondence should be addressed.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
G. Tuteja, S. T. Jensen, P. White, and K. H. Kaestner
Cis-regulatory modules in the mammalian liver: composition depends on strength of Foxa2 consensus site
Nucleic Acids Res., July 1, 2008; 36(12): 4149 - 4157.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
T M Murphy, A S Perry, and M Lawler
The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer
Endocr. Relat. Cancer, March 1, 2008; 15(1): 11 - 25.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. E. K. Ibrahim, N. P. Thorne, K. Baird, N. L. Barbosa-Morais, S. Tavare, V. P. Collins, A. H. Wyllie, M. J. Arends, and J. D. Brenton
MMASS: an optimized array-based method for assessing CpG island methylation
Nucleic Acids Res., November 6, 2006; 34(20): e136 - e136.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A. S Perry, R. Foley, K. Woodson, and M. Lawler
The emerging roles of DNA methylation in the clinical management of prostate cancer.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 357 - 377.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
M. P. Lee, K. Howcroft, A. Kotekar, H. H. Yang, K. H. Buetow, and D. S. Singer
ATG deserts define a novel core promoter subclass
Genome Res., September 1, 2005; 15(9): 1189 - 1197.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. T. Bommer, C. Jager, E.-M. Durr, S. Baehs, S. T. Eichhorst, T. Brabletz, G. Hu, T. Frohlich, G. Arnold, D. C. Kress, et al.
DRO1, a Gene Down-regulated by Oncogenes, Mediates Growth Inhibition in Colon and Pancreatic Cancer Cells
J. Biol. Chem., March 4, 2005; 280(9): 7962 - 7975.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.